Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-05
2006-09-05
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S105000
Reexamination Certificate
active
07101876
ABSTRACT:
The present invention relates to a class of compounds represented by the formula (I)or a pharmaceutical acceptable salt, prodrug or ester thereof, pharmaceutical compositions comprising compounds of the formula (I), and methods of selectively inhibiting or antagonizing αvβ3integrin.
REFERENCES:
patent: 6750215 (2004-06-01), Vianello et al.
patent: WO 00/39103 (1999-07-01), None
patent: WO 99/50257 (2000-06-01), None
Montgomery et al.,Proc. Natl. Acad. Sci.USA, vol. 91, pp. 8856-8860, Sep. 1994.
Seftor, et al.,Proc. Natl. Acad. Sci.USA, vol. 89, pp. 1557-1561, Mar. 1992.
Adamis, et al.,Amer. J. Opthal.,vol. 118, p. 445-450, Oct. 1994.
Peacock, et. al.,J. Exp. Med.,J. Exp. Med., vol. 175, p. 1135-1138, Apr. 1992.
Brooks, et al.,Cell, vol. 79, pp. 1157-1164, Dec. 1994.
Brooks, et al.,Science, vol. 264, pp. 569-571, Apr. 1994.
Sato, et al.,J. Cell Biol.,vol. 111, pp. 1713-1723, Oct. 1990.
Fisher, et al.,Endocrinology, vol. 132(3), pp. 1411-1413, 1993.
Choi, et al.,J. Vasc. Surg.,vol. 19(1), pp. 125-134, Jan. 1994.
White, J.M.,Current Biology, vol. 3(9), pp. 596-599, 1993.
Verlag,Methods of Organic Chemistry(Houben-Weil), vol. E 9a, pp. 141-177, Stuttgart 1997.
Krchnak, V., Flegelova, Z., Weichsel, A.S., Lebl, M.,Tetrahedron Letters, vol. 36(35), pp. 6193-6196, 1995.
Brown, R.F.C., Jackson, W.R., McCarthy, T.D.,Tetrahedron, vol. 50(18), pp. 5469-5488, 1994.
Beier, C., Schaumann, E.,Synthesis, vol. 11, pp. 1296-1300, Jul. 1997.
Hinterberger, S., Hofer, O., Greger, H.,Tetrahedroni, vol. 54, pp. 487-496, 1998.
Van Heerden, P.S., Bezuidenhoudt, B.C.B., Ferreira, D.,Tetrahedron1996, 52, 12313-12322.
Van Heerden, P.S., Bezuidenhoudt, B.C.B., Ferreira, D.,J. Chem. Soc. Perk. Trans. 1, 1997, 1141-1146.
Greene, T.W., Wuts, P.G.M.,Protective Groups in Organic Synthesis, Wiley, 1999.
Miller, W.H. et al.,Bioorg. Med. Chem. Lett.,vol. 9, pp. 1807-1812, 1999.
Erez, M., et al.,J. Med. Chem.1978, 21, 982-984.
Young, R.N., Gauthier, J.Y., Coombs, W.,Tetrahedron Lett.,vol. 25(17), pp. 1753-1756, 1984.
Yadagiri, B. Lown, J.W.,Synthetic Communications, vol. 20(2), pp. 175-181, 1990.
Wong, et al.,Molecular Pharmacology50:529-537, 1996.
Pytela, et al.,Methods in Enzymology, vol. 144, pp. 475-489, 1987.
Berryman, et al.,Chemical Abstracts, vol. 131:257572, 1999.
Bandiera Tiziano
Vianello Paola
Habte Kahsay
Pharmacia Corporation
Pugmire Matthew J.
Zielinski Bryan C.
LandOfFree
Substituted benzoxazines as integrin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzoxazines as integrin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzoxazines as integrin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3576734